Code
MOG-IMAX-03AZ
Test
Active-Compendium
81120, 81121
81479
Clinical
Oncology,Pathology
Peripheral blood: 5 mL in EDTA tube.
Bone marrow: 2 mL in EDTA tube.
FFPE solid tumor tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Note: Test is DNA-based. Please select Extract & Hold - DNA if specimen hold service is desired.
Bone marrow: 2 mL in EDTA tube.
FFPE solid tumor tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Note: Test is DNA-based. Please select Extract & Hold - DNA if specimen hold service is desired.
Flag Active
True
Orderable Test Description
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true" data-pm-slice="1 1 []">This is a real-time PCR test that detects of mutations in IDH1 at codons R132X and R100Q and at IDH2 codons R140X and R172X. IDH1 and IDH2 are analyzed concurrently.</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">Test Customization: This test is also available through the Servier-sponsored IDH testing program initiative called IDHNow for AML. Only patients who meet all of the following criteria shall be eligible to participate in the Servier-sponsored IDH testing program:</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient has newly diagnosed AML, not previously treated</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient lives and receives treatment in the United States or a US territory</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient does not have a known <em data-prosemirror-content-type="mark" data-prosemirror-mark-name="em">IDH1 </em>mutation from a previous test</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient has not previously been tested under this program </p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">A patient who applies and meets the criteria listed above shall be deemed eligible for the STP without regard to any prescription, order, or purchase of any drug, product, or service from SERVIER, NeoGenomics, or its Affiliates.</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">A separate test form is required. Please visit test requisition page to download.</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">Test Customization: This test is also available through the Servier-sponsored IDH testing program initiative called IDHNow for AML. Only patients who meet all of the following criteria shall be eligible to participate in the Servier-sponsored IDH testing program:</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient has newly diagnosed AML, not previously treated</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient lives and receives treatment in the United States or a US territory</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient does not have a known <em data-prosemirror-content-type="mark" data-prosemirror-mark-name="em">IDH1 </em>mutation from a previous test</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">· Patient has not previously been tested under this program </p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">A patient who applies and meets the criteria listed above shall be deemed eligible for the STP without regard to any prescription, order, or purchase of any drug, product, or service from SERVIER, NeoGenomics, or its Affiliates.</p>
<p data-prosemirror-content-type="node" data-prosemirror-node-name="paragraph" data-prosemirror-node-block="true">A separate test form is required. Please visit test requisition page to download.</p>
Orderable Turn Around Time
5 Days
Extra Note
Please select extract & hold - DNA if specimen hold service is desired. Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.
NY Approved
True
Orderable Biomarkers JSON
{"DNA Sequencing": {"SNVs + Indels": ["IDH1", "IDH2"]}}
Keywords string
idh1, idh2, Molecular , IDH IDHNow (IDH1/IDH2 Mutation Analysis by PCR)
Title URL
idhnow-idh1-idh2-mutation-analysis-by-pcr